178 related articles for article (PubMed ID: 24820230)
1. The effect of carbohydrate moiety structure on the immunoregulatory activity of lactoferrin in vitro.
Zimecki M; Artym J; Kocięba M; Duk M; Kruzel ML
Cell Mol Biol Lett; 2014 Jun; 19(2):284-96. PubMed ID: 24820230
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune response.
Choi BK; Actor JK; Rios S; d'Anjou M; Stadheim TA; Warburton S; Giaccone E; Cukan M; Li H; Kull A; Sharkey N; Gollnick P; Kocieba M; Artym J; Zimecki M; Kruzel ML; Wildt S
Glycoconj J; 2008 Aug; 25(6):581-93. PubMed ID: 18365311
[TBL] [Abstract][Full Text] [Related]
3. Characterization of recombinant human lactoferrin N-glycans expressed in the milk of transgenic cows.
Parc AL; Karav S; Rouquié C; Maga EA; Bunyatratchata A; Barile D
PLoS One; 2017; 12(2):e0171477. PubMed ID: 28170415
[TBL] [Abstract][Full Text] [Related]
4. Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily.
Kelm S; Pelz A; Schauer R; Filbin MT; Tang S; de Bellard ME; Schnaar RL; Mahoney JA; Hartnell A; Bradfield P
Curr Biol; 1994 Nov; 4(11):965-72. PubMed ID: 7533044
[TBL] [Abstract][Full Text] [Related]
5. Novel recombinant human lactoferrin: differential activation of oxidative stress related gene expression.
Kruzel ML; Actor JK; Zimecki M; Wise J; Płoszaj P; Mirza S; Kruzel M; Hwang SA; Ba X; Boldogh I
J Biotechnol; 2013 Dec; 168(4):666-75. PubMed ID: 24070904
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive characterization of the site-specific N-glycosylation of wild-type and recombinant human lactoferrin expressed in the milk of transgenic cloned cattle.
Yu T; Guo C; Wang J; Hao P; Sui S; Chen X; Zhang R; Wang P; Yu G; Zhang L; Dai Y; Li N
Glycobiology; 2011 Feb; 21(2):206-24. PubMed ID: 20943674
[TBL] [Abstract][Full Text] [Related]
7. CHO expressed recombinant human lactoferrin as an adjuvant for BCG.
Hwang SA; Kruzel ML; Actor JK
Int J Immunopathol Pharmacol; 2015 Dec; 28(4):452-68. PubMed ID: 26315722
[TBL] [Abstract][Full Text] [Related]
8. Lactoferrin, a Critical Player in Neonate Intestinal Development: RHLF may be a Good Choice in Formula.
Wang W; Cheng Z; Wang X; An Q; Huang K; Dai Y; Meng Q; Zhang Y
J Agric Food Chem; 2021 Aug; 69(31):8726-8736. PubMed ID: 34323077
[TBL] [Abstract][Full Text] [Related]
9. Effect of lactoferrin on the methotrexate-induced suppression of the cellular and humoral immune response in mice.
Artym J; Zimecki M; Kruzel ML
Anticancer Res; 2004; 24(6):3831-6. PubMed ID: 15736418
[TBL] [Abstract][Full Text] [Related]
10. The role of N-linked glycosylation in the protection of human and bovine lactoferrin against tryptic proteolysis.
van Veen HA; Geerts ME; van Berkel PH; Nuijens JH
Eur J Biochem; 2004 Feb; 271(4):678-84. PubMed ID: 14764083
[TBL] [Abstract][Full Text] [Related]
11. High-Level Expression of Recombinant Bovine Lactoferrin in Pichia pastoris with Antimicrobial Activity.
Iglesias-Figueroa B; Valdiviezo-Godina N; Siqueiros-Cendón T; Sinagawa-García S; Arévalo-Gallegos S; Rascón-Cruz Q
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27294912
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human lactoferrin induces apoptosis, disruption of F-actin structure and cell cycle arrest with selective cytotoxicity on human triple negative breast cancer cells.
Iglesias-Figueroa BF; Siqueiros-Cendón TS; Gutierrez DA; Aguilera RJ; Espinoza-Sánchez EA; Arévalo-Gallegos S; Varela-Ramirez A; Rascón-Cruz Q
Apoptosis; 2019 Aug; 24(7-8):562-577. PubMed ID: 30941553
[TBL] [Abstract][Full Text] [Related]
13. [Animal experiment of recombinant human lactoferrin based on the 28 days repeated oral toxicity].
Ma B; Yuan X; Wang X; Gao P; Zhao Z; Yang J; Peng S; Xu H
Wei Sheng Yan Jiu; 2017 May; 46(3):443-454. PubMed ID: 29903257
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human lactoferrin as a biomaterial for bone tissue engineering: mechanism of antiapoptotic and osteogenic activity.
Amini AA; Nair LS
Adv Healthc Mater; 2014 Jun; 3(6):897-905. PubMed ID: 24352833
[TBL] [Abstract][Full Text] [Related]
15. Orally administered lactoferrin restores humoral immune response in immunocompromised mice.
Artym J; Zimecki M; Paprocka M; Kruzel ML
Immunol Lett; 2003 Oct; 89(1):9-15. PubMed ID: 12946859
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin and Nrf2: key factors in the neuroprotection provided by apo-lactoferrin.
Zakharova ET; Sokolov AV; Pavlichenko NN; Kostevich VA; Abdurasulova IN; Chechushkov AV; Voynova IV; Elizarova AY; Kolmakov NN; Bass MG; Semak IV; Budevich AI; Kozhin PM; Zenkov NK; Klimenko VM; Kirik OV; Korzhevskii DE; Menshchikova EB; Vasilyev VB
Biometals; 2018 Jun; 31(3):425-443. PubMed ID: 29748743
[TBL] [Abstract][Full Text] [Related]
17. Role of sialylated glycans on bovine lactoferrin against influenza virus.
Wang X; Yue L; Dang L; Yang J; Chen Z; Wang X; Shu J; Li Z
Glycoconj J; 2021 Dec; 38(6):689-696. PubMed ID: 34779975
[TBL] [Abstract][Full Text] [Related]
18. Lactoferrin and desferrioxamine are ineffective in the treatment of Helicobacter pylori infection and may enhance H. pylori growth and gastric inflammation in mice.
Huynh HQ; Campbell MA; Couper RT; Tran CD; Lawrence A; Butler RN
Lett Appl Microbiol; 2009 May; 48(5):517-22. PubMed ID: 19187488
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory properties of human recombinant lactoferrin in mice: Implications for therapeutic use in humans.
Artym J; Kocięba M; Zaczyńska E; Adamik B; Kübler A; Zimecki M; Kruzel M
Adv Clin Exp Med; 2018 Mar; 27(3):391-399. PubMed ID: 29533543
[TBL] [Abstract][Full Text] [Related]
20. Lactoferrin inhibits the effector phase of the delayed type hypersensitivity to sheep erythrocytes and inflammatory reactions to M. bovis (BCG).
Zimecki M; Machnicki M
Arch Immunol Ther Exp (Warsz); 1994; 42(3):171-7. PubMed ID: 7487348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
